Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Makiko Shimizu

Showing results (1-10 of 248) with videos related to

Pageof 25
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 3, 2009
[Individual differences of drug-metabolizing enzymes as determinants for the metabolic fate of chemicals--a study of trimethylamine and flavin-containing monooxygenase 3-]Makiko Shimizu
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 30, 2022
Species Specificity and Selection of Models for Drug Oxidations Mediated by Polymorphic Human EnzymesHiroshi Yamazaki, Makiko Shimizu
The Journal of Toxicological Sciences|July 19, 2017
Human plasma and urinary metabolic profiles of trimethylamine and trimethylamine N-oxide extrapolated using a simple physiologically based pharmacokinetic modelMakiko Shimizu, Hiroshi Yamazaki
Chemical Research in Toxicology|July 8, 2025
Prediction of Internal Exposures after Virtual Oral Doses of Disparate Chemicals in Rats and Humans Using Simplified Physiologically Based Pharmacokinetic Models with <i>In Silico-</i>Generated Input ParametersHiroshi Yamazaki, Makiko Shimizu
Current Drug Metabolism|June 23, 2007
Genetic polymorphism of the flavin-containing monooxygenase 3 (FMO3) associated with trimethylaminuria (fish odor syndrome): observations from Japanese patientsHiroshi Yamazaki, Makiko Shimizu
Biochemical Pharmacology|April 10, 2013
Survey of variants of human flavin-containing monooxygenase 3 (FMO3) and their drug oxidation activitiesHiroshi Yamazaki, Makiko Shimizu
Cancer Chemotherapy and Pharmacology|August 31, 2002
Mechanisms of the apoptotic activity of Cl-F-araA in a human T-ALL cell line, CCRF-CEMTakeshi Takahashi, Makiko Shimizu, Shiro Akinaga
Biochemical Pharmacology|April 30, 2013
Molecular and functional characterization of flavin-containing monooxygenases in cynomolgus macaqueYasuhiro Uno, Makiko Shimizu, Hiroshi Yamazaki
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 16, 2003
[What doctors expect of a pharmacist's work--how a pharmacist is evaluated by doctors]Yoshiaki Matsumoto, Makiko Shimizu, Masamichi Fukuoka
The Journal of Toxicological Sciences|November 3, 2022
Updated in silico prediction methods for fractions absorbed and absorption rate constants of 372 disparate chemicals for use in physiologically based pharmacokinetic models for estimating internal concentrations in ratsKoichiro Adachi, Makiko Shimizu, Hiroshi Yamazaki
Pageof 25

Showing results (1-10 of 248) with videos related to

Sort By:
Pageof 25
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|November 3, 2009
[Individual differences of drug-metabolizing enzymes as determinants for the metabolic fate of chemicals--a study of trimethylamine and flavin-containing monooxygenase 3-]Makiko Shimizu
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 30, 2022
Species Specificity and Selection of Models for Drug Oxidations Mediated by Polymorphic Human EnzymesHiroshi Yamazaki, Makiko Shimizu
The Journal of Toxicological Sciences|July 19, 2017
Human plasma and urinary metabolic profiles of trimethylamine and trimethylamine N-oxide extrapolated using a simple physiologically based pharmacokinetic modelMakiko Shimizu, Hiroshi Yamazaki
Chemical Research in Toxicology|July 8, 2025
Prediction of Internal Exposures after Virtual Oral Doses of Disparate Chemicals in Rats and Humans Using Simplified Physiologically Based Pharmacokinetic Models with <i>In Silico-</i>Generated Input ParametersHiroshi Yamazaki, Makiko Shimizu
Current Drug Metabolism|June 23, 2007
Genetic polymorphism of the flavin-containing monooxygenase 3 (FMO3) associated with trimethylaminuria (fish odor syndrome): observations from Japanese patientsHiroshi Yamazaki, Makiko Shimizu
Biochemical Pharmacology|April 10, 2013
Survey of variants of human flavin-containing monooxygenase 3 (FMO3) and their drug oxidation activitiesHiroshi Yamazaki, Makiko Shimizu
Cancer Chemotherapy and Pharmacology|August 31, 2002
Mechanisms of the apoptotic activity of Cl-F-araA in a human T-ALL cell line, CCRF-CEMTakeshi Takahashi, Makiko Shimizu, Shiro Akinaga
Biochemical Pharmacology|April 30, 2013
Molecular and functional characterization of flavin-containing monooxygenases in cynomolgus macaqueYasuhiro Uno, Makiko Shimizu, Hiroshi Yamazaki
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 16, 2003
[What doctors expect of a pharmacist's work--how a pharmacist is evaluated by doctors]Yoshiaki Matsumoto, Makiko Shimizu, Masamichi Fukuoka
The Journal of Toxicological Sciences|November 3, 2022
Updated in silico prediction methods for fractions absorbed and absorption rate constants of 372 disparate chemicals for use in physiologically based pharmacokinetic models for estimating internal concentrations in ratsKoichiro Adachi, Makiko Shimizu, Hiroshi Yamazaki
Pageof 25